Becton Dickinson (BDX) Research & Development (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Research & Development of $249.0 million for Q1 2026, up 7.33% year-over-year from $232.0 million in Q1 2025, and down 18.63% quarter-over-quarter from $306.0 million in Q4 2025.
Becton Dickinson (BDX) Research & Development (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Research & Development for 18 consecutive years, with $249.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 7.33% year-over-year to $249.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (changed 0.17% YoY), while the FY2025 annual figure was $1.3 billion, up 6.3% from the prior year.
- Research & Development eased to $249.0 million in Q1 2026 per BDX's latest filing, from $306.0 million in the prior quarter.
- Across five years, Research & Development topped out at $343.0 million in Q4 2024 and bottomed at $232.0 million in Q1 2025.
- Historically, Research & Development has averaged $301.1 million across 5 years, with a median of $302.0 million in 2024.
- Annual changes were most pronounced in 2024 — Research & Development increased 18.28% — and 2025, when it declined 22.41%.
- Becton Dickinson's Research & Development stood at $313.0 million in 2022, then dropped by 7.35% to $290.0 million in 2023, then gained by 18.28% to $343.0 million in 2024, then fell by 10.79% to $306.0 million in 2025, then fell by 18.63% to $249.0 million in 2026.
- Business Quant data shows BDX's Research & Development at $249.0 million in Q1 2026, $306.0 million in Q4 2025, and $322.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 258.00 Mn |
| Mar 31, 2026 | 249.00 Mn |
| Dec 31, 2025 | 306.00 Mn |
| Sep 30, 2025 | 322.00 Mn |
| Jun 30, 2025 | 297.00 Mn |
| Mar 31, 2025 | 232.00 Mn |
| Dec 31, 2024 | 343.00 Mn |
| Sep 30, 2024 | 302.00 Mn |
| Jun 30, 2024 | 299.00 Mn |
| Mar 31, 2024 | 299.00 Mn |
| Dec 31, 2023 | 290.00 Mn |
| Sep 30, 2023 | 281.00 Mn |
| Jun 30, 2023 | 306.00 Mn |
| Mar 31, 2023 | 337.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 300.00 Mn |
| Jun 30, 2022 | 315.00 Mn |
| Mar 31, 2022 | 327.00 Mn |
| Dec 31, 2021 | 314.00 Mn |
| Sep 30, 2021 | 368.00 Mn |